Technical Analysis for AVGR - Avinger, Inc.

Grade Last Price % Change Price Change
F 1.42 -11.80% -0.19
AVGR closed down 11.8 percent on Friday, July 26, 2024, on 23.91 times normal volume. The bears made the stock sink to a new 52-week low. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Hammer Candlestick Bullish 0.00%
Volume Surge Other 0.00%
New 52 Week Low Weakness 0.00%
Earnings Movers Other 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Gapped Down Weakness 0.00%
20 DMA Resistance Bearish -11.80%

   Recent Intraday Alerts

Alert Time
2x Volume Pace about 11 hours ago
1.5x Volume Pace about 11 hours ago
3x Volume Pace about 11 hours ago
10x Volume Pace about 11 hours ago
5x Volume Pace about 11 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Avinger, Inc. Description

Avinger, Inc., a medical device company, designs, manufactures, and sells image-guided, catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD). It offers Lightbox, an imaging console, which enables the use of lumivascular catheters during PAD procedures; Ocelot, a chronic total occlusion (CTO) crossing catheter, which allows physicians to see the inside of an artery during a CTO crossing procedure; Ocelot PIXL, a lower profile CTO-crossing device for below-the-knee arteries; and Ocelot MVRX, a device which offers a tip design for above-the-knee arteries. The company also provides Wildcat, a catheter that facilitates the intraluminal placement of conventional guidewires beyond stenotic lesions in the peripheral vasculature prior to further percutaneous intervention; and Kittycat 2, a catheter that facilitate the intraluminal placement of conventional guidewires beyond stenotic lesions in the peripheral vasculature prior to further percutaneous intervention. The company offers its products to interventional cardiologists, vascular surgeons, and interventional radiologists directly in the United States and Europe. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Imaging Catheter Medical Imaging Interventional Radiology Knee Artery Cordis Interventional Cardiology Percutaneous Peripheral Arterial Disease

Is AVGR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.0
52 Week Low 1.22
Average Volume 40,767
200-Day Moving Average 3.06
50-Day Moving Average 2.05
20-Day Moving Average 1.70
10-Day Moving Average 1.69
Average True Range 0.15
RSI (14) 29.58
ADX 32.88
+DI 13.13
-DI 39.34
Chandelier Exit (Long, 3 ATRs) 1.57
Chandelier Exit (Short, 3 ATRs) 1.68
Upper Bollinger Bands 1.87
Lower Bollinger Band 1.53
Percent B (%b) -0.31
BandWidth 20.10
MACD Line -0.13
MACD Signal Line -0.14
MACD Histogram 0.0105
Fundamentals Value
Market Cap 1.82 Million
Num Shares 1.28 Million
EPS -30.21
Price-to-Earnings (P/E) Ratio -0.05
Price-to-Sales 0.48
Price-to-Book 1.56
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.84
Resistance 3 (R3) 1.82 1.66 1.77
Resistance 2 (R2) 1.66 1.55 1.67 1.75
Resistance 1 (R1) 1.54 1.49 1.46 1.56 1.72
Pivot Point 1.38 1.38 1.34 1.39 1.38
Support 1 (S1) 1.26 1.27 1.18 1.28 1.12
Support 2 (S2) 1.10 1.21 1.11 1.09
Support 3 (S3) 0.98 1.10 1.07
Support 4 (S4) 1.00